An attempt has been made to replicate an earlier finding that type A botulinum toxin can inhibit the in vitro activity of acetylcholinesterase. Two methods of enzyme assay were employed, but with neither technique were we able to reproduce the finding of in vitro enzyme inhibition. In fact, an examination of the data from the previous report leads us to question the possibility of the observations that were given. Furthermore, an investigation was carried out to determine if botulinum toxin can exert an inhibiting effect on acetylcholinesterase that is situated in the biological tissue. The answer again is negative. The experimental observations, coupled with several mathematical computations, do not support the notion that botulinum toxin is an acetylcholinesterase inhibitor.
The cholinolytic effect of botulinum toxin is believed to be caused by the action of this poison in suppressing the presynatic release of acetylcholine (ACh; 1). Study supporting this theory has originated almost entirely from observations on the peripheral nervous system or on in vitro preparations. Two recent reports have noted that in the central nervous system (CNS) of mammals suffering botulinal intoxication there results a dramatic increase in the brain stores of ACh (3, 7) . It was postulated that the increased levels of ACh were indicative of the poison's acting on the CNS in a manner similar to that on the peripheral nervous system; thus, the suppressed release of ACh caused a damming and internal buildup of neurohumor.
A recent study indicates that botulinum toxin, in a physical system that contains no biological tissue, is able to inhibit acetylcholinesterase (AChE; 6). The observation raises the question of whether the previously noted CNS increases in tissues levels of ACh reflect (i) suppressed release of ACh which is thereby protected from hydrolysis, or (ii) normal metabolic production of ACh during inhibition of its degrading enzyme. To choose between these two alternatives, we proceeded to replicate the above finding of an AChE inhibition by botulinum toxin and additionally to determine if the effect was demonstrable in vivo or in vitro. The temperature and duration of assay were identical to those previously used (6) . The toxin concentration was varied by steps of 10, from 10-' to 10-8 mg/ ml for both assays. Optical density changes due to enzyme activity were followed with a Gilford model 2000 recording spectrophotometer.
MATERIALS AND METHODS
In 
RESULTS AND DISCUSSION
In the initial experiment, using the Kramer and Gamson assay, the concentration of reactants, as suggested in the earlier publication, were AChE = 0.17 unit/ml (Marshall and Quinn state a value of 5.0 units/ml. However, their number is based on a unit of enzyme activity being that amount which hydrolyzes 10.1 ,ug of ACh/min at 37 C, thus the difference in units per milliliter. It must be emphasized, nonetheless, that although there is a disparity in terms of "units" of enzyme per milliliter, the activity per milliliter in both studies is identical); botulinum toxin = 3.3 X 10-6 mg, and IPA = 1.3 X 10-6 M. Under these conditions, we were unable to detect any inhibition of AChE whatsoever; for in fact we were unable to detect a measurable reaction rate of IPA hydrolysis. The inactivity was manifest both in the presence and in the absence of botulinum toxin; thus, enzyme inhibition could not have been the determinant. Additionally, AChE was increased and decreased, in separate tests, by a factor of 10, neither alteration producing a definitive reaction rate.
This puzzling result prompted us to investigate the simple kinetics of the AChE-IPA reaction and further to delineate the conditions under which one might expect to witness a measureable hydrolysis rate. For these purposes, an absorption spectrum of indophenol, the hydrolysis and spectrophotometrically active product of IPA, was taken. The compound has a major peak at 625 nm, and at this peak, the molar absorptivity coefficient is 8,160 (Fig. 1 ). With these data, one may use the Beer-Lambert law to ascertain the maximal optical density change that any given concentration of IPA will produce when completely converted by enzyme to indophenol. 25 % inhibition (6) .
To ensure that we were not in error by using the older assay technique, the ElIman et al. method was used. Even when the toxin concentration was raised to 10-2 mg/ml, we could see no inhibition of enzyme activity.
At b Unit refers to the amount of enzyme which hydrolyzes 1 jsmole of ACh/min at 27 C.
-Number refers to milligram of toxin per assay.
of their unit, one may calculate that these investigators used sufficient enzyme to hydrolyze 3.8 X 101' molecules of ACh/hr in the presence of 3.3 X 10-6 mg of toxin and one-tenth that amount in the presence of 3.3 X 10-"0 mg of toxin. This represents 2 x 1011 and 2 x 1010, molecules, respectively, of AChE per assay.
Botulinum toxin has an approximate weight of 900,000. Consequently, 10-6 mg of toxin per 3 ml reaction cuvette means approximately 2 X 109 molecules of toxin; similarly, 10-10 mg means approximately 2 X 106 molecules of toxin.
It is interesting to pair the data derived from these computations. According to the earlier report (6), 2 X 106 molecules of toxin can produce nearly 25% inhibition of 2 X 1010 molecules of AChE, and 2 X 109 molecules of toxin can produce the same order of inhibition of 2 x 1011 molecules of AChE. An enzyme inhibitor-enzyme ratio of 1:100,000, with a resulting 25% inhibition, is most phenomenal. We were unable to obtain the result. Furthermore, by use of the Ellman et al. technique, with 10-2mg of toxin, the toxin to enzyme ratio was nearly 1:1. No positive result, i.e., enzyme inhibition, was obtained here.
Two factors may have contributed to the failure to replicate the earlier reported result of inhibition. First, our investigation was performed by using glass apparatus, whereas the earlier study used plastic ware. This may have produced a difference in that the glassware could conceivably bind, by polar charges, the small quantities of toxin. Indeed, a difference in result depending on whether glass or plastic ware is used has been noted (R. Marshall, personal communication). However, the importance of this observation is questionable, because all cuvettes used for spectrophotometric study are made of glass. Second, all toxin maintained in our laboratory is stored in phosphate-buffered gelatin solution with glycerol, but the earlier investigators used unbuffered saline. It is conceivable that bonds between the toxin and either the gelatin or the phosphate shielded the groups that might otherwise react with AChE.
In this context, there are three notes which should be made on the data presented in the Marshall and Quinn report. First, the optical density changes for all the control preparations are identical. This could mean that the investigators enjoyed remarkable success in running the various control preparations. More likely, a single control or control condition was run, and this value was used in calculating all the data. Such a method is faulty, for one should run a control or standard for each condition. Thus, we would expect to see differences between those preparations which contained, and those which did not contain, antitoxin; we would even expect to see small differences among the various antitoxin preparations. Second, the data show an identical optical density change for a preparation containing 5 units of enzyme/ml and a preparation containing 0.5 unit/ml, the latter reaction running 2.5 times longer than the former. The observation is unlikely. Finally, the values given must obviously be the means of the several experiments, In any event, we proceeded to examine the possibility that botulinum toxin could inhibit AChE when the enzyme was still situated in biological tissue. The examination had two approaches. In the first, toxin (1O02 mg) was administered into the lateral tail vein of rats. When the animals were moribund (the moribund state of the animals showed dramatically that the molecular moiety responsible for the poison's toxicity was not shielded), they were decapitated and decorticated. The cortices were analyzed for AChE and BuChE by the modified Ellman et al. technique (2) . In the second approach, cortices were removed from rats, and 10 mg of toxin was added to the cortex homogenate. This second approach was employed to circumvent the criticism that botulinum toxin does not always successfully invade the CNS. Figures 2 and 3 show the results of these in vivo and in vitro experiments. In neither instance is there inhibition of either AChE or BuChE.
No determination of peripheral levels of the esterases was made because there already exist data which suggest no inhibition of AChE by botulinum toxin at the motor end plate. Both 0.8- But because of the 3-ml volume of the cuvette and the microscopic volume of the synapse, the toxin is far more concentrated in the synapse. Even if one assumes that the 103 molecules in the single section represent all the toxin molecules present at the end plate, the toxin is still considerably more concentrated at the neuromuscular junction than in the cuvette. Under these circumstances, it is curious that no in vivo inhibition of AChE, as evidenced by fasciculation in the poisoned animals, is observed. The curiosity is magnified when it is considered that the cuvette contained orders of magnitude more AChE than is present at the synapse. We thus arrive at the paradox that in the synapse, in which one encounters relatively concentrated toxin and relatively unconcentrated AChE, there is no inhibition; whereas in the cuvette, in which one encounters relatively dilute toxin and relatively concentrated AChE, there is reported inhibition.
From our data and calculations, we draw the following conclusion. There is no in vivo inhibition of AChE by botulinum toxin type A either in the CNS or in the peripheral nervous system. Furthermore, we find the inhibition of AChE by toxin, in a system lacking biological tissue, not to be a universally demonstrable phenomenon. The latter comment is very much in agreement with the recent note of Sumyl and Yocum (8) .
